Skip to main content

Table 3 Estimated marginal means of T cell marker surface area (μm2) in cows

From: Prediction of Johne’s disease state based on quantification of T cell markers and their interaction with macrophages in the bovine intestine

  Status
  Control Subclinical Clinical
CCR9 23.23 ± 1.34 20.98 ± 1.31 140.15 ± 1.31
 Pr(> t) 1.89E−44 2.27E−49 4.12E−89
CD4 585.79 ± 1.23 585.21 ± 1.21 424.80 ± 1.21
 Pr(> t) 6.39E−119 2.05E−129 3.11E−125
CD8α 810.48 ± 1.21 842.23 ± 1.19 514.45 ± 1.19
 Pr(> t) 1.71E−127 5.36E−140 8.33E−132
CXCR3 116.29 ± 14.81 177.98 ± 14.21 1538.85 ± 13.66
 Pr(> t) 4.99E−16 3.42E−27 3.77E−76
FoxP3 1111.78 ± 1.11 711.20 ± 1.10 520.61 ± 1.10
 Pr(> t) 6.61E−177 4.21E−182 1.45E−176
TcR1-N24 1194.59 ± 1.15 1222.86 ± 1.13 506.25 ± 1.13
 Pr(> t) 2.10E−150 3.91E−163 1.87E−148
  1. Estimated marginal means (+ 1 ± SEM) were generated by generalized linear mixed modeling using the following formula: Tcell ~ Status for subclinically (n = 10) and clinically (n = 10) cows infected with MAP, as compared to noninfected control cows (n = 8).
  2. SEM, standard error of the mean; Pr(> t), p-value for t statistic.